TALL-104 and Gleevec in Chronic Myelogenous Leukemia Patients
Clinical trial NCT00415909 · TERMINATED
Trial details
- NCT number
- NCT00415909
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2013-05-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.